Founded with the mission to revolutionize epilepsy care, EpiWatch is a digital health company dedicated to improving the lives of individuals with epilepsy. The company focuses on delivering innovative and integrated services that enhance safety, enable better condition management for patients, caregivers, and physicians, and provide peace of mind for loved ones. EpiWatch's primary product is a digital platform designed for the detection and management of tonic-clonic seizures, aiming to lead the digital transformation in epilepsy care.
EpiWatch has garnered attention from notable figures in the medical and tech industries, as well as investors committed to advancing healthcare technology. The company has achieved significant milestones in clinical studies related to seizure detection, contributing valuable data and insights to the field of epilepsy care. Through its pioneering efforts, EpiWatch has made a substantial impact on the quality of life for people with epilepsy, setting new standards for digital health solutions in neurological care.
